Newish Investor31 Jan 2023 19:57
I recently became a new investor here. So maybe someone could answer the following.
After reading the latest report i could not see anything mentioning the possibility of a pharma licencing into the company. I know this is slightly different in terms of phase1, 2.3 and fda clearence being met, but surely there is an interest out there. I am assuming that the company wants to hold onto as much as possibly of the products for future revenue, but for example a multinational being involved would fund future developments going forward.
Hopefully big pharma will start to take an interest in the products as they certainly do come across as very exctiting on a number of fronts inmv.